SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,803.00
+170.00 (10.41%)
Mar 5, 2026, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 153.7 billion as of March 5, 2026. Its market cap has increased by 11.09% in one year.
Market Cap
153.70B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
12.09
Stock Price
1,803.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 153.70B, an increase of 759.38%. That is a compound annual growth rate of 7.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 153.70B | 6.73% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 220.32B |
| JW Lifescience | 202.07B |
| AptaBio Therapeutics | 198.34B |
| REYON Pharmaceutical | 194.96B |
| Hana Pharm | 179.51B |
| Daihan Pharmaceutical | 176.69B |
| Dongwha Pharm.Co.,Ltd | 170.47B |
| Whan In Pharm | 163.20B |